Mathew S. George

Canberra, ACT, AU 
Canberra, ACT, AU 

Overview

Mathew George practices practicing medicine in Canberra, Australia.

His clinical expertise encompasses Neurogenic Bladder, Acute Pain, Essential Thrombocythemia, and Lung Adenocarcinoma.

He is actively involved in clinical research, co-authoring 60 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Canberra, ACT, Australia
Other Locations
Newcastle, NSW, Australia
Sydney, NSW 2145, Australia
Tamworth, NSW, Australia
Westmead, NSW, Australia
Armidale, NSW, Australia
Building 22, University Drive, ACT 261, Bruce, ACT, Australia
NSW, Australia
Hunter, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial
Enrollment Status: Unknown
Publish Date: February 02, 2024
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
A Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602).
A Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602).
Enrollment Status: Unknown
Publish Date: February 16, 2022
Intervention Type: Drug
Study Drugs: Nivolumab, Ipilimumab
Study Phase: Phase 2
View 1 Less Clinical Trial

60 Total Publications

Metastatic Colorectal Cancer as a Chronic Disease: Twelve-Year Survival After Initially Unresectable Bilobar Liver Metastases.
Metastatic Colorectal Cancer as a Chronic Disease: Twelve-Year Survival After Initially Unresectable Bilobar Liver Metastases.
Journal: Cureus
Published: March 26, 2026

Frequently Asked Questions about Mathew S. George

Is Mathew S. George a top-rated expert for Neurogenic Bladder?

MediFind is an objective health platform that identifies experts based on real-world data. Mathew S. George is classified as an Experienced expert for Neurogenic Bladder, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mathew S. George participate in research or clinical trials?

Yes. Mathew S. George has published 60 articles and abstracts on conditions like Neurogenic Bladder. You can view a list of Mathew S. George's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. George's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile